In clinical trials, the new drug, BG-12, has been shown to lower the number of nerve cell attacks with fewer side effects. It is expected to cost about $50,000 a year, the same as other similar drugs. NBC’s Robert Bazell reports.Sept. 20, 2012
UP NEXT
L.A. schools close over employee strike
00:22
Macron survives no-confidence vote making new French pension plan law
02:34
New Miami Beach curfew voted down as city faces spring break violence
03:37
Oklahoma police captain asks officer to turn off bodycam during DUI arrest